Genericart Metoprolol Succinate 12.5mg Tablet ER
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Metoprolol Succinate (11.8mg)
Overview Genericart Metoprolol Succinate 12.5mg Tablet ER
Metoprolol Succinate ER 12.5mg tablets (Genericart) are beta-blockers used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also helps prevent migraines and reduces the risk of future strokes and myocardial infarctions. Prescribed individually or in conjunction with other therapies, dosage and frequency are condition-specific. Administer consistently at the same time daily, with or without food, for optimal effectiveness. Full therapeutic benefits may take several weeks to manifest, and continuous use is often necessary, even with symptom improvement; discontinuation may worsen underlying conditions. Common, generally mild and transient, side effects include fatigue, cephalalgia, depressive mood, diarrhea, skin rashes, bradycardia, lightheadedness, and nausea. Less frequent adverse effects may include dyspnea and hypotension. Gradual dose escalation minimizes side effect risks. Report persistent or bothersome side effects to your physician. Prior to initiating treatment, inform your doctor of any hepatic impairment, pre-existing bradycardia, severe circulatory issues, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. Always discuss suitability with your physician, and maintain regular blood pressure monitoring to confirm therapeutic efficacy. Alcohol consumption should be limited due to potential side effect exacerbation.
Uses of Genericart Metoprolol Succinate 12.5mg Tablet ER
Managing angina pectoris (chest pain of cardiac origin) | Addressing cardiac arrhythmias | Reducing the risk of myocardial infarction | Hypertension (high blood pressure) management | Migraine prophylaxis
Major Benefits of Genericart Metoprolol Succinate 12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Genericart Metoprolol Succinate 12.5mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods, including olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and meat, while taking this medicine.
Common Side effects of Genericart Metoprolol Succinate 12.5mg Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Genericart Metoprolol Succinate 12.5mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Genericart Metoprolol Succinate 12.5mg Extended-Release tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. To optimize absorption, avoid consuming Genericart Metoprolol Succinate 12.5mg Tablet ER with meals high in fat, including foods like olive oil, nuts (especially Brazil nuts), dark chocolate, butter, and red meat.
How Genericart Metoprolol Succinate 12.5mg Tablet ER works:
Metoprolol Succinate Extended-Release 12.5mg tablets (Genericart) are a sustained-release beta-adrenergic blocking agent targeting cardiac function. Their mechanism of action involves reducing heart rate and improving the heart's pumping efficiency, thereby enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Genericart Metoprolol Succinate 12.5mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release metoprolol succinate 12.5 mg tablets (generic) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Metoprolol succinate extended-release 12.5 mg tablets (Genericart) are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Extended-release Metoprolol Succinate 12.5mg tablets (Genericart) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release metoprolol succinate tablets (12.5 mg) marketed as Genericart are considered safe for patients with impaired renal function. No dosage modification is necessary for this medication in such patients.
LiverCAUTION
Extended-release metoprolol succinate 12.5mg tablets require careful consideration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Genericart Metoprolol Succinate 12.5mg Tablet ER :
Should you forget a dose of your Genericart Metoprolol Succinate 12.5mg Extended-Release tablet, take it immediately. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Genericart Metoprolol Succinate 12.5mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |

